G6PD Cancer Research Results
G6PD, Glucose-6-phosphate dehydrogenase: Click to Expand ⟱
| Source: |
| Type: |
Glucose-6-phosphate dehydrogenase (G6PD) is an enzyme that plays a crucial role in the pentose phosphate pathway (PPP), a metabolic pathway that generates NADPH and pentoses from glucose-6-phosphate. G6PD is the first enzyme in the PPP and is responsible for catalyzing the conversion of glucose-6-phosphate to 6-phosphogluconate, producing NADPH in the process.
**** patients who receive intravenous ascorbate must be prescreened for glucose 6 phosphate dehydrogenase deficiency.
G6PD expression is often elevated in various cancers and is generally linked to poorer prognosis.
|
Scientific Papers found: Click to Expand⟱
| - |
vitro+vivo, |
BC, |
MDA-MB-231 |
|
|
|
TumCI↓, G6PD↓, HK2↓, Glycolysis↓, TumMeta↓,
| - |
in-vivo, |
BC, |
MDA-MB-231 |
|
|
|
TumMeta↓, HK2↓, TumCI↓, TumCMig↓, Glycolysis↓, G6PD↓,
Ferroptosis↑, GutMicro↑, Akt↓, mTOR↓, NF-kB↓, Wnt↓, β-catenin/ZEB1↓, STAT3↓, TumCP↓, TumCI↓, TumMeta↓, AMPK↑, P53↑, NRF2↑, TumCCA↑, Apoptosis↑, Casp↑, GPx4↓, DNMTs↓, HDAC↓, VEGF↓, Imm↑, NK cell↑, Warburg↓, Hif1a↓, HK2↓, PKM2↓, LDHA↓, GLUT1↓, MCT1↓, AMPK↑, FASN↓, SCD1↓, GLS↓, Apoptosis↑, ETC↓, MMP↓, ROS↑, lipid-P↑, ChemoSen↑, PDK1↓, Beclin-1↓, ATP↓, Glycolysis↓, GlucoseCon↓, lactateProd↑, MMPs↓, GSH↓, G6PD↓, OXPHOS↓, SREBP2↓, COX2↓, AP-1↓, NADH↓, NRF2↑, HO-1↑, Iron↑, MDA↑, *ROS↓, *Inflam↓,
G6PD↓, PCNA↓, cycD1/CCND1↓, P21↑, Hif1a↓, Glycolysis↓,
Glycolysis↓, GLUT1↓, PFK1↓, Hif1a↓, ROS↑, PDH↑, AMPK↑, TumCG↓, TumCI↓, TumCP↓, p‑NF-kB↓, SIRT1↑, SIRT3↑, LDH↓, PI3K↓, mTOR↓, PKM2↓, R5P↝, G6PD↓, TKT↝, talin↓, HK2↓, GRP78/BiP↑, GlucoseCon↓, ER Stress↑, Warburg↓, PFK↓,
| - |
in-vitro, |
GBM, |
U87MG |
|
|
|
- |
in-vivo, |
GBM, |
NA |
|
|
|
- |
in-vitro, |
GBM, |
U251 |
|
|
|
RIP1↑, RIP3↑, Glycolysis↓, G6PD↓, HK2↓, PKM2↓, H2O2↑, GSH↓, ROS↑,
Showing Research Papers: 1 to 6 of 6
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 6
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
Ferroptosis↑, 1, GPx4↓, 1, GSH↓, 2, H2O2↑, 1, HO-1↑, 1, Iron↑, 1, lipid-P↑, 1, MDA↑, 1, NADH↓, 1, NRF2↑, 2, OXPHOS↓, 1, ROS↑, 3, SIRT3↑, 1, TKT↝, 1,
Mitochondria & Bioenergetics ⓘ
ATP↓, 1, ETC↓, 1, MMP↓, 1,
Core Metabolism/Glycolysis ⓘ
AMPK↑, 3, FASN↓, 1, G6PD↓, 6, GLS↓, 1, GlucoseCon↓, 2, Glycolysis↓, 6, HK2↓, 5, lactateProd↑, 1, LDH↓, 1, LDHA↓, 1, PDH↑, 1, PDK1↓, 1, PFK↓, 1, PFK1↓, 1, PKM2↓, 3, R5P↝, 1, SCD1↓, 1, SIRT1↑, 1, SREBP2↓, 1, Warburg↓, 2,
Cell Death ⓘ
Akt↓, 1, Apoptosis↑, 2, Casp↑, 1, Ferroptosis↑, 1, MCT1↓, 1, RIP1↑, 1,
Protein Folding & ER Stress ⓘ
ER Stress↑, 1, GRP78/BiP↑, 1,
Autophagy & Lysosomes ⓘ
Beclin-1↓, 1,
DNA Damage & Repair ⓘ
DNMTs↓, 1, P53↑, 1, PCNA↓, 1,
Cell Cycle & Senescence ⓘ
cycD1/CCND1↓, 1, P21↑, 1, TumCCA↑, 1,
Proliferation, Differentiation & Cell State ⓘ
HDAC↓, 1, mTOR↓, 2, PI3K↓, 1, STAT3↓, 1, TumCG↓, 1, Wnt↓, 1,
Migration ⓘ
AP-1↓, 1, MMPs↓, 1, RIP3↑, 1, talin↓, 1, TumCI↓, 4, TumCMig↓, 1, TumCP↓, 2, TumMeta↓, 3, β-catenin/ZEB1↓, 1,
Angiogenesis & Vasculature ⓘ
Hif1a↓, 3, VEGF↓, 1,
Barriers & Transport ⓘ
GLUT1↓, 2,
Immune & Inflammatory Signaling ⓘ
COX2↓, 1, Imm↑, 1, NF-kB↓, 1, p‑NF-kB↓, 1, NK cell↑, 1,
Drug Metabolism & Resistance ⓘ
ChemoSen↑, 1,
Clinical Biomarkers ⓘ
GutMicro↑, 1, LDH↓, 1,
Total Targets: 78
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
ROS↓, 1,
Immune & Inflammatory Signaling ⓘ
Inflam↓, 1,
Total Targets: 2
Scientific Paper Hit Count for: G6PD, Glucose-6-phosphate dehydrogenase
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:1 prod#:% Target#:808 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page